Harry Perkins Institute of Medical Research

OncoRes Medical today announced it has closed an AUD $27M private funding round (‘the Funding round’) to progress clinical development and regulatory milestones for its Quantitative Micro-Elastography (QME) Imaging System, Elora™.

Perth-based OncoRes Medical has secured $27 million from Brandon Capital's BB6 Fund, Morgans, Radar Ventures and others to advance its Elora breast-surgery imaging device through an Australian clinical trial toward FDA approval.

Also oncoresmedical.com

Perth infection management medtech Cytophenix prescribed $1.3 million in pre-Seed

Perth medtech spin-out Cytophenix raised a pre-seed round above its target to advance trials and grow the team behind FloCAST, a rapid test identifying effective antibiotics, after earlier grants and accelerator programs.

Eight Aussie startups that raised $108.6 million this week

Roundup of eight funding deals: Synchron's Series D, plus raises by Lumonus AI, Hullbot, Nbryo, Cytophenix, Giftbee, Understanding Zoe and Zeligate, spanning medtech, robotics, agtech and AI.

Also Startup Daily·Startup Daily·Startup Daily·Startup Daily·SmartCompany·Startup Daily·Startup Daily

Western Australia launches $150 million startup investment program, backing 7 VCs with $45m

Western Australia's government added $15 million to its WAVC fund-of-funds, committing $45 million across seven venture firms to back local startups; Purpose Ventures' fund closed at $55 million after backing My Mirror and SpacetoCo.

State Government Backs OncoRes Medical with Funding to Manufacture Digital Cancer ImagingDevice in WA

OncoRes Medical has received a $3 million WA government grant to manufacture its surgical cancer-imaging device locally, its latest funding after a 2022 Series A2 and earlier state and federal grants.

Also Brandon BioCatalyst portfolio·Startup News (WA)

Australian medical device company secures additional $12.5m to advance its breast cancer imaging system towards clinical trials

Perth medtech OncoRes Medical announced $12.5 million: a $9.5 million Series A2 co-led by Brandon Capital and Australian Unity, plus a $3 million government grant, and hired a new R&D vice president.

Also Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Startup News (WA)

OncoRes Medical receives $150,000 funding boost from Western Australian Government

The Western Australian Government is putting $150,000 from its New Industries Fund into medtech startup OncoRes Medical to expand R&D and jobs, with the company also recalling $7.5 million raised from MRCF.

Also Brandon Capital portfolio·Startup News (WA)

OncoRes Medical wins IGNITE Madness 2020

Perth medtech OncoRes Medical won the IGNITE Madness 2020 pitch competition in Houston, earning a US$10,000 cash prize plus a Texas Medical Centre Ventures investment prize valued above US$100,000.

OncoRes Medical awarded prestigious research funding

OncoRes Medical received grant funding through the third round of MTPConnect's BMTH program to develop a second-generation imaging device for breast-conserving surgery, the article's profile states.

Also Brandon Capital portfolio·Brandon Capital portfolio·Startup News (WA)